| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/08/2023 | 35.66% | JP Morgan | $8 → $7 | Maintains | Underweight |
| 08/08/2023 | 55.04% | Stifel | $15 → $8 | Maintains | Hold |
| 08/08/2023 | 55.04% | JP Morgan | $15 → $8 | Downgrades | Neutral → Underweight |
| 07/14/2023 | — | Needham | Downgrades | Buy → Hold | |
| 04/20/2023 | 403.88% | Needham | → $26 | Reiterates | → Buy |
| 02/28/2023 | 403.88% | Needham | → $26 | Reiterates | → Buy |
| 02/24/2023 | 403.88% | Needham | $36 → $26 | Maintains | Buy |
| 01/17/2023 | — | William Blair | Downgrades | Outperform → Market Perform | |
| 11/03/2022 | 326.36% | JP Morgan | $32 → $22 | Maintains | Neutral |
| 11/02/2022 | 597.67% | Needham | $45 → $36 | Maintains | Buy |
| 05/09/2022 | 481.4% | Stifel | $40 → $30 | Maintains | Hold |
| 05/06/2022 | 772.09% | Needham | $47 → $45 | Maintains | Buy |
| 12/09/2021 | 810.85% | Needham | → $47 | Upgrades | Hold → Buy |
| 11/08/2021 | 675.19% | Stifel | $70 → $40 | Maintains | Hold |
| 11/05/2021 | 713.95% | SVB Leerink | $72 → $42 | Maintains | Market Perform |
| 11/02/2021 | 772.09% | JP Morgan | $71 → $45 | Upgrades | Underweight → Neutral |
| 08/05/2021 | — | Keybanc | Downgrades | Overweight → Sector Weight | |
| 06/04/2021 | — | William Blair | Upgrades | Market Perform → Outperform | |
| 05/05/2021 | 1295.35% | SVB Leerink | $67 → $72 | Maintains | Market Perform |
| 05/05/2021 | 1353.49% | Keybanc | $60 → $75 | Maintains | Overweight |
| 02/25/2021 | 946.51% | SVB Leerink | $47 → $54 | Maintains | Market Perform |
| 12/14/2020 | 1062.79% | Keybanc | → $60 | Upgrades | Sector Weight → Overweight |
| 08/05/2020 | 578.29% | SVB Leerink | $42 → $35 | Maintains | Market Perform |
| 07/23/2020 | — | Needham | Downgrades | Buy → Hold | |
| 06/11/2020 | — | William Blair | Downgrades | Outperform → Market Perform | |
| 06/01/2020 | 713.95% | SVB Leerink | $56 → $42 | Maintains | Market Perform |
| 05/06/2020 | 985.27% | SVB Leerink | $68 → $56 | Maintains | Market Perform |
| 05/06/2020 | 1353.49% | Needham | $80 → $75 | Maintains | Buy |
| 02/26/2020 | 772.09% | JP Morgan | $60 → $45 | Maintains | Underweight |
| 12/20/2019 | 1062.79% | JP Morgan | $47.5 → $60 | Maintains | Underweight |
| 11/06/2019 | 1644.19% | Needham | → $90 | Upgrades | Hold → Buy |
| 08/08/2019 | 810.85% | SVB Leerink | $78 → $47 | Downgrades | Outperform → Market Perform |
| 08/08/2019 | 830.23% | Stifel | $85 → $48 | Downgrades | Buy → Hold |
| 07/03/2019 | 1295.35% | JP Morgan | → $72 | Downgrades | Neutral → Underweight |
| 06/28/2019 | — | Needham | Downgrades | Strong Buy → Buy | |
| 05/08/2019 | 1547.29% | Stifel | $160 → $85 | Maintains | Buy |
| 05/08/2019 | 1295.35% | JP Morgan | $175 → $72 | Downgrades | Overweight → Neutral |
| 11/20/2018 | 5326.36% | Needham | → $280 | Upgrades | Buy → Strong Buy |
What is the target price for Inogen (INGN)?
The latest price target for Inogen (NASDAQ: INGN) was reported by JP Morgan on November 8, 2023. The analyst firm set a price target for $7.00 expecting INGN to rise to within 12 months (a possible 35.66% upside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Inogen (INGN)?
The latest analyst rating for Inogen (NASDAQ: INGN) was provided by JP Morgan, and Inogen maintained their underweight rating.
When is the next analyst rating going to be posted or updated for Inogen (INGN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Inogen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Inogen was filed on November 8, 2023 so you should expect the next rating to be made available sometime around November 8, 2024.
Is the Analyst Rating Inogen (INGN) correct?
While ratings are subjective and will change, the latest Inogen (INGN) rating was a maintained with a price target of $8.00 to $7.00. The current price Inogen (INGN) is trading at is $5.16, which is out of the analyst's predicted range.
